University of Wisconsin
Pulmonary and Critical Care fellowship · Madison, WI · Program website
This program's roster hasn't been collected yet, so there's no list of its own faculty and papers. Below is University of Wisconsin–Madison's research in pulmonary and critical care, which the program shares with other departments and affiliated hospitals.
About University of Wisconsin–Madisoninstitution-wide pulmonary and critical care research
Pulmonary and Critical Care publications from University of Wisconsin–Madison and affiliated institutions, since 2022. Updated 2026-11-06; refreshed daily.
243
works per year
16th of 79 pulmonary and critical care fellowship programs
+21.9%
2-year growth
18th of 79 pulmonary and critical care fellowship programs
29.4%
in top 10% of field (works before 2025)
7th of 74 pulmonary and critical care fellowship programs
54.0%
cited above world average
4th of 74 pulmonary and critical care fellowship programs
Works per year · * 2026 so far
Pulmonary and Respiratory Medicine · 1,116Critical Care and Intensive Care Medicine · 144
Pulmonary and Critical Care research topics at University of Wisconsin–Madison
Papers in the window; each links to the list on OpenAlex.
- Asthma and respiratory diseases 97
- Veterinary Oncology Research 73
- Intensive Care Unit Cognitive Disorders 65
- Renal cell carcinoma treatment 64
- Radiation Therapy and Dosimetry 63
- Prostate Cancer Treatment and Research 61
- Cystic Fibrosis Research Advances 59
- Pulmonary Hypertension Research and Treatments 52
Most cited at University of Wisconsin–Madison since 2024
All pulmonary and critical care papers there on OpenAlex
- Non–Small Cell Lung Cancer, Version 4.2024Gregory J. Riely et al. · Journal of the National Comprehensive Cancer Network · 2024 · PubMed · cited 897
- 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic DiseasesSindhu R. Johnson et al. · Arthritis & Rheumatology · 2024 · PubMed · cited 211
- NCCN Guidelines® Insights: Kidney Cancer, Version 2.2024Robert John Motzer et al. · Journal of the National Comprehensive Cancer Network · 2024 · PubMed · cited 201
- 2023 American College of Rheumatology ( ACR )/American College of Chest Physicians ( CHEST ) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic DiseasesSindhu R. Johnson et al. · Arthritis & Rheumatology · 2024 · PubMed · cited 167
- Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic PhenotypeDavid J. Jackson et al. · New England Journal of Medicine · 2024 · PubMed · cited 166
- 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic DiseasesSindhu R. Johnson et al. · Arthritis Care & Research · 2024 · PubMed · cited 142
- Vanzacaftor–tezacaftor–deutivacaftor versus elexacaftor–tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103): results from two randomised, active-controlled, phase 3 trialsClaire L. Keating et al. · The Lancet Respiratory Medicine · 2025 · PubMed · cited 132
- Individualized Treatment Effects of Oxygen Targets in Mechanically Ventilated Critically Ill AdultsKevin G. Buell et al. · JAMA · 2024 · PubMed · cited 130
- Asthma Inception: Epidemiologic Risk Factors and Natural History Across the Life CourseErik Melén et al. · American Journal of Respiratory and Critical Care Medicine · 2024 · PubMed · cited 108
- Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3 studyMohamad Ezzeddine Allaf et al. · The Lancet Oncology · 2024 · PubMed · cited 101